Clincosm LogoSign in Get a demo

Narcolepsy

Showing 1 - 25 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Narcolepsy Trial in Taoyuan ("MAGSTIM" reprtitive Transcranial Magnetic Stimulator (rTMS) System, sham control)

Recruiting
  • Narcolepsy
  • "MAGSTIM" reprtitive Transcranial Magnetic Stimulator (rTMS) System
  • sham control
  • Taoyuan, Taiwan
    Chang-Gung Memorial Hospital
May 30, 2023

Idiopathic Hypersomnia, Narcolepsy Trial (JZP258 (XYWAV))

Not yet recruiting
  • Idiopathic Hypersomnia
  • Narcolepsy
  • JZP258 (XYWAV)
  • (no location specified)
May 16, 2023

Discovering Factors in Narcolepsy Patients' Clinical Research

Not yet recruiting
  • Narcolepsy
    • (no location specified)
    May 12, 2023

    Narcolepsy Trial in Worldwide (JZP258)

    Not yet recruiting
    • Narcolepsy
    • Encino, California
    • +17 more
    May 12, 2023

    Narcolepsy, Social Cognition Trial in Amiens (Questionary)

    Recruiting
    • Narcolepsy
    • Social Cognition
    • Questionary
    • Amiens, France
      CHU Amiens-Picardie
    Mar 17, 2023

    Narcolepsy, Narcolepsy Type 1, Narcolepsy With Cataplexy Trial in Chicago (Imagery rehearsal therapy, Targeted dream control)

    Not yet recruiting
    • Narcolepsy
    • +4 more
    • Imagery rehearsal therapy
    • Targeted dream control
    • Chicago, Illinois
      Northwestern University
    Jan 24, 2023

    Hypersomnia, Narcolepsy Trial (Dreem 3 System At-Home Monitoring)

    Not yet recruiting
    • Hypersomnia
    • Narcolepsy
    • Dreem 3 System At-Home Monitoring
    • (no location specified)
    Jan 17, 2023

    Narcolepsy, Obstructive Sleep Apnea, Shift Work Sleep Disorder Trial in West Chester (Modafinil/armodafinil)

    Recruiting
    • Narcolepsy
    • +2 more
    • West Chester, Pennsylvania
      Teva Pregnancy Registry
    Dec 13, 2022

    Narcolepsy, Idiopathic Hypersomnia, Cataplexy Trial (Quantitative mass spectrometry assay)

    Not yet recruiting
    • Narcolepsy
    • +2 more
    • Quantitative mass spectrometry assay
    • (no location specified)
    Nov 7, 2022

    Narcolepsy Trial in Bologna (Tele-multidisciplinary care, Standard care)

    Active, not recruiting
    • Narcolepsy
    • Tele-multidisciplinary care
    • Standard care
    • Bologna, Italy
      Irccs - Istituto Delle Scienze Neurologiche
    Nov 9, 2022

    Narcolepsy Trial in Osaka And Other Japanese City, Seoul And Other Korean City (TS-091 5mg, TS-091 10mg, Placebo)

    Completed
    • Narcolepsy
    • TS-091 5mg
    • +2 more
    • Osaka And Other Japanese City, Japan
    • +1 more
    Oct 4, 2022

    Narcolepsy, Cataplexy, Excessive Daytime Sleepiness Trial in Canada, United States (AXS-12 (reboxetine), Placebo)

    Enrolling by invitation
    • Narcolepsy
    • +2 more
    • AXS-12 (reboxetine)
    • Placebo
    • Santa Ana, California
    • +18 more
    Sep 23, 2022

    Narcolepsy, Cataplexy, Excessive Daytime Sleepiness Trial in Canada, United States (AXS-12 (reboxetine), Placebo)

    Recruiting
    • Narcolepsy
    • +2 more
    • AXS-12 (reboxetine)
    • Placebo
    • Alabaster, Alabama
    • +45 more
    Sep 23, 2022

    Sleep Disorder, Sleep Disorder Parasomnia, Narcolepsy Trial in Mainz (no interventions, only observation)

    Recruiting
    • Sleep Disorder
    • +8 more
    • Implantation of vagus nerve stimulation according to clinical indication
    • Mainz, Rheinland-Pfalz, Germany
      Mainz Comprehensive Epilepsy and Sleep Medicine Center
    Sep 11, 2022

    Narcolepsy Trial in Canada, United States (SUVN-G3031, Placebo)

    Recruiting
    • Narcolepsy
    • Birmingham, Alabama
    • +40 more
    Sep 9, 2022

    Pregnancy Related, Narcolepsy Trial in Morrisville (Pitolisant, Comparator Products)

    Recruiting
    • Pregnancy Related
    • Narcolepsy
    • Morrisville, North Carolina
      Evidera (PPD)
    Sep 7, 2022

    Narcolepsy, Excessive Daytime Sleepiness, Cataplexy Narcolepsy Trial in United States (mazindol extended release, Placebo)

    Completed
    • Narcolepsy
    • +2 more
    • mazindol extended release
    • Placebo
    • Birmingham, Alabama
    • +21 more
    Aug 11, 2022

    Narcolepsy Trial in United States (JZP-258)

    Recruiting
    • Narcolepsy
    • Alabaster, Alabama
    • +27 more
    Jul 22, 2022

    Narcolepsy, Narcolepsy Without Cataplexy, Narcolepsy With Cataplexy Trial in Chicago (Brief MBI, Standard MBI, Extended MBI)

    Completed
    • Narcolepsy
    • +2 more
    • Brief MBI
    • +2 more
    • Chicago, Illinois
      Center for Circadian and Sleep Medicine, Northwestern University
    Jun 30, 2022

    A Patient-Centric, Prospective, Observational,

    Completed
    • Narcolepsy
    • Transition from Xyrem to Xywav
    • Palo Alto, California
      Jazz Pharmaceuticals Clinical Site
    Jun 27, 2022

    Narcolepsy With Cataplexy, Narcolepsy, Narcolepsy Without Cataplexy Trial in United States (Mazindol)

    Enrolling by invitation
    • Narcolepsy With Cataplexy
    • +2 more
    • Birmingham, Alabama
    • +21 more
    Jun 1, 2022

    Pediatric Narcolepsy Patient Reported Outcomes Scale

    Recruiting
    • Narcolepsy
    • Obstructive Sleep Apnea
      • Boston, Massachusetts
        Boston Children's Hospital
      May 26, 2022

      Cardiovascular and Cognitive Implications of Central Disorders

      Enrolling by invitation
      • Narcolepsy
      • Idiopathic Hypersomnia
      • 24-hour Ambulatory Blood Pressure Monitoring
      • Oculo-Cognitive Addition Test (OCAT)
      • Scottsdale, Arizona
        Mayo Clinic Arizona
      May 27, 2022

      Narcolepsy, Idiopathic Hypersomnia, Hypersomnolence Disorder Trial in Bern

      Recruiting
      • Narcolepsy
      • +2 more
        • Bern, Switzerland
          Claudio L Bassetti
        May 17, 2022

        Narcolepsy Trial in Palo Alto

        Completed
        • Narcolepsy
          • Palo Alto, California
            Jazz Pharmaceuticals
          Apr 1, 2022